Cellebrite Di Equity Stock Current Valuation
| CLBTWDelisted Stock | USD 5.15 0.44 7.87% |
Valuation analysis of Cellebrite DI Equity helps investors to measure Cellebrite's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Cellebrite's price fluctuation is relatively risky at this time. Calculation of the real value of Cellebrite DI Equity is based on 3 months time horizon. Increasing Cellebrite's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Cellebrite stock is determined by what a typical buyer is willing to pay for full or partial control of Cellebrite DI Equity. Since Cellebrite is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cellebrite Stock. However, Cellebrite's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.15 | Real 4.03 | Hype 5.28 | Naive 4.53 |
The intrinsic value of Cellebrite's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Cellebrite's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Cellebrite DI Equity helps investors to forecast how Cellebrite stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cellebrite more accurately as focusing exclusively on Cellebrite's fundamentals will not take into account other important factors: Cellebrite DI Equity Company Current Valuation Analysis
Cellebrite's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Cellebrite DI Equity has a Current Valuation of 0.0. This is 100.0% lower than that of the Software sector and about the same as Information Technology (which currently averages 0.0) industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Cellebrite Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cellebrite's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cellebrite could also be used in its relative valuation, which is a method of valuing Cellebrite by comparing valuation metrics of similar companies.Cellebrite is currently under evaluation in current valuation category among its peers.
Cellebrite Fundamentals
| Return On Equity | -17.69 | |||
| Return On Asset | 0.0639 | |||
| Profit Margin | (0.29) % | |||
| Operating Margin | 0.13 % | |||
| Number Of Shares Shorted | 356.81 K | |||
| Price To Earning | 12.50 X | |||
| Revenue | 325.11 M | |||
| Gross Profit | 219.91 M | |||
| EBITDA | 43.29 M | |||
| Net Income | (81.1 M) | |||
| Total Debt | 14.13 M | |||
| Book Value Per Share | (0.19) X | |||
| Cash Flow From Operations | 102.06 M | |||
| Earnings Per Share | 0.06 X | |||
| Number Of Employees | 1.01 K | |||
| Beta | 1.52 | |||
| Total Asset | 540.4 M | |||
| Retained Earnings | 118.14 M | |||
| Working Capital | 168.26 M | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 540.4 M |
About Cellebrite Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cellebrite DI Equity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cellebrite using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cellebrite DI Equity based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Cellebrite Stock
If you are still planning to invest in Cellebrite DI Equity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cellebrite's history and understand the potential risks before investing.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |